כל המחקרים
גיוסשלב 3התערבותי

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

This study wants to find out if taking a 1mg minoxidil tablet every day is a safe and effective way to treat a common type of female hair loss called androgenetic alopecia. Researchers will compare this tablet to a 2% minoxidil solution that you put on your skin, and also to a dummy tablet or cream (a placebo) that contains no active medicine. The main goals are to see if the tablet works as well as the skin solution, or even better than the dummy treatment, and to make sure it's safe for patients. The study lasts about 36 weeks and involves different groups getting various combinations of these treatments.

במבט חטוף

סטטוס
גיוס
שלב
שלב 3
נותן חסות
Industrial Farmacéutica Cantabria, S.A.
יעד הרשמה
520
התחל
17 אוקטובר 2024
השלמה משוערת
01 נובמבר 2026

על מה המחקר הזה?

This study is about a type of hair loss common in women, called androgenetic alopecia. It's often linked to hormones. Researchers want to see if a daily 1mg tablet of minoxidil can help grow hair and make it thicker. Minoxidil is already used in a solution you put on your scalp, and this study aims to find out if a tablet form is just as helpful, or even more so, for this kind of hair loss.

To do this, the study will compare a daily minoxidil tablet against two other treatments. One is the familiar 2% minoxidil solution applied to the skin. The other is a "placebo," which looks exactly like the real medicine but has no active ingredients. This helps researchers understand if any changes are truly due to the minoxidil or something else.

Ultimately, the main goal is to understand if the minoxidil tablet is both effective and safe for women with this type of hair loss. The study is a "Phase III" trial, which means it's a larger study designed to confirm the results of earlier, smaller studies before a new treatment can be considered for wider use.

נקודות עיקריות

  • This study is testing a minoxidil tablet for female hair loss.
  • It compares the tablet to a skin solution and a dummy treatment.
  • The study lasts about 36 weeks and requires regular visits and checks.
  • You won't know if you're getting the active drug or a placebo.
  • You must be a woman aged 18 or over with specific hair loss symptoms and generally good health.

מי עשוי להיות זכאי?

This study is looking for women aged 18 or older who are generally healthy. You would need to have been diagnosed with female androgenetic alopecia, which means a noticeable thinning of hair, particularly on the top and crown of your head, as described by a specific hair loss scale.

It's important that you don't have any serious health problems, especially heart conditions, or any skin conditions on your scalp that might interfere with the study. If you could become pregnant, you'll need to have negative pregnancy tests and agree to use highly effective birth control throughout the study and for a short time afterwards. Also, your hair colour needs to stand out enough against your scalp for photos to be taken easily.

Finally, you should be willing to keep your hairstyle and hair care routine the same during the study, as well as your body hair removal habits. You'd also need to attend all scheduled appointments and follow the study instructions carefully.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. Are you a woman aged 18 or older?
  2. Have you been diagnosed with female pattern hair loss (androgenetic alopecia) on your scalp?
  3. Are you generally healthy, without heart problems or other significant illnesses?
  4. If you can get pregnant, are you willing to use effective birth control throughout the study?
  5. Are you able to attend regular appointments and follow study instructions?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you join this study, it will last up to 36 weeks (about 8 to 9 months). You'll be randomly placed into one of three groups. One group will take the minoxidil tablet and use a dummy skin solution. A second group will take a dummy tablet and use the 2% minoxidil skin solution. The third group will take a dummy tablet and use a dummy skin solution.

You'll visit the study centre 5 times during this period for check-ups and observations. There will also be 2 phone calls. At your visits, doctors will take photos of your hair to check for growth, measure your blood pressure, pulse, and body temperature. You'll also have a general health check, blood tests, urine tests, and an ECG (heart tracing). They will also look for any unwanted hair growth on your body. You'll be asked daily to record any side effects, new medications, or procedures. If you could become pregnant, you'll have regular pregnancy tests.

סיכונים ותועלות פוטנציאליים

Participating in this study might mean you see an improvement in your hair loss if the minoxidil tablet works for you. You'll also receive careful medical monitoring throughout the study, which is a benefit. However, like all medications, minoxidil can have side effects, such as unwanted hair growth elsewhere on the body or changes in blood pressure. The dummy treatments (placebos) have no active ingredients, so they carry no drug-related risks, but also no direct benefits for hair growth. You have the right to withdraw from the study at any time and for any reason, without it affecting your usual medical care.

מיקומים (13)

  • Fachklinik Bad Bentheim Klinisches Studienzentrum
    מיקוד מאומת
    Bad Bentheim, Germany· גיוס
  • CRC - Charité Universitätsmedizin Berlin Clinical Research Center for Hair and Skin Science
    מיקוד מאומת
    ברלין, גרמניה· גיוס
  • emovis by Futuremeds GmbH
    מיקוד מאומת
    ברלין, גרמניה· גיוס
  • Rosenpark Reasearch GmbH
    מיקוד מאומת
    Darmstadt, Germany· עדיין לא מגייסים
  • Privatpraxis Dr. Hilton & Partner
    מיקוד מאומת
    דיסלדורף, גרמניה· Terminated
  • Klinik für Dermatologie, Venerologie und Allergologie - Universitätsmedizin Frankfurt
    מיקוד מאומת
    פרנקפורט, גרמניה· גיוס
  • Dermaticum -Dr. med. Mario Bittar und Kollegen
    מיקוד מאומת
    פרייבורג אים ברייסגאו, גרמניה· גיוס
  • Eurofins bioskin - Research Center Dermatology
    מיקוד מאומת
    המבורג, גרמניה· גיוס
  • Klinische Forschung Karlsruhe GmbH
    מיקוד מאומת
    Karlsruhe, Germany· גיוס
  • Siteworks - Prüfzentrum Lohne
    מיקוד מאומת
    Löhne, Germany· פעיל אך לא מגייס
  • Zentrale Studienkoordination für innovative Dermatologie (ZiD) Klinik für Hautkrankheiten Universitätsklinikum Münster (UKM)
    מיקוד מאומת
    Münster, Germany· נמשך
  • Haut-und Lasercentrum - Dr. Tanja Fischer und Kollegen
    מיקוד מאומת
    Potsdam, Germany· גיוס

שאלות נפוצות

What is androgenetic alopecia?

It's a common type of hair loss in women, often called female pattern baldness, which is thought to be linked to hormones.

מהו 'פלצבו'?

A placebo is a dummy treatment that looks like the real medicine but contains no active ingredients. It helps researchers compare how well the actual medicine works.

כמה זמן יימשך המחקר?

The study will last for up to 36 weeks, which is about 8 to 9 months.

Will I know if I'm getting the real medicine or the dummy treatment?

No, this is a 'double-blind' study, meaning neither you nor your doctor will know which treatment you are receiving until after the study is over. This helps keep the results fair.

What kind of tests will I have during the study?

You'll have hair photos, blood tests, urine tests, ECGs, and general health checks, including blood pressure and temperature measurements.

כיצד לגלות עוד

Ana López-Ballesteros

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in …" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.